ARCHIVES

News Analysis: IOM Report A Case Study In Communications Disaster

This article is from The Cancer Letter archive.

Vol. 25 No. 05 | February 5, 1999

Download PDF Visit The Full Archive

Related Articles

Phase III Xilonix Study Halted Following Unscheduled Analysis

September 26, 2014

FTC Report Disagrees With Key Provision Of Biologics Bill Backed By Companies

June 12, 2009

National Cancer Policy Forum Studies Modernization, Funding Of Cooperative Group Program.

July 11, 2008

NCI To Use Technology Transfer Agreement To Privatize Journal In A Five-Year Deal

December 1, 1995

Lilly Made False Claims About Ralozifene Reducing Breast Cancer risk, Judge Rules

July 30, 1999

NCI subsidy of $2 million paid major expenses of rescheduled meeting.

April 15, 2005